These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1512692)
1. Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoprotein-expressing cells. Puri A; Dimitrov DS; Golding H; Blumenthal R J Acquir Immune Defic Syndr (1988); 1992; 5(9):915-20. PubMed ID: 1512692 [TBL] [Abstract][Full Text] [Related]
2. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. Raja NU; Vincent MJ; Jabbar MA J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933 [TBL] [Abstract][Full Text] [Related]
3. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction. Dimitrov DS; Broder CC; Berger EA; Blumenthal R J Virol; 1993 Mar; 67(3):1647-52. PubMed ID: 8437234 [TBL] [Abstract][Full Text] [Related]
4. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS. Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H AIDS; 1992 Mar; 6(3):249-56. PubMed ID: 1348943 [TBL] [Abstract][Full Text] [Related]
5. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes. Dimitrov AS; Xiao X; Dimitrov DS; Blumenthal R J Biol Chem; 2001 Aug; 276(32):30335-41. PubMed ID: 11397808 [TBL] [Abstract][Full Text] [Related]
6. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. Sattentau QJ; Moore JP J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252 [TBL] [Abstract][Full Text] [Related]
7. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time. Golding H; Blumenthal R; Manischewitz J; Littman DR; Dimitrov DS J Virol; 1993 Nov; 67(11):6469-75. PubMed ID: 8411350 [TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4. Ashorn P; Berger EA; Moss B Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369 [No Abstract] [Full Text] [Related]
9. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein. Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475 [TBL] [Abstract][Full Text] [Related]
10. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Moore JP; McKeating JA; Weiss RA; Sattentau QJ Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501 [TBL] [Abstract][Full Text] [Related]
11. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. Jones PL; Korte T; Blumenthal R J Biol Chem; 1998 Jan; 273(1):404-9. PubMed ID: 9417096 [TBL] [Abstract][Full Text] [Related]
12. Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles. Neurath AR; Strick N; Jiang S; Li YY; Debnath AK BMC Infect Dis; 2002 Apr; 2():6. PubMed ID: 11983022 [TBL] [Abstract][Full Text] [Related]
13. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. Fu YK; Hart TK; Jonak ZL; Bugelski PJ J Virol; 1993 Jul; 67(7):3818-25. PubMed ID: 8510207 [TBL] [Abstract][Full Text] [Related]
14. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. Finzi A; Xiang SH; Pacheco B; Wang L; Haight J; Kassa A; Danek B; Pancera M; Kwong PD; Sodroski J Mol Cell; 2010 Mar; 37(5):656-67. PubMed ID: 20227370 [TBL] [Abstract][Full Text] [Related]
15. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. Haim H; Si Z; Madani N; Wang L; Courter JR; Princiotto A; Kassa A; DeGrace M; McGee-Estrada K; Mefford M; Gabuzda D; Smith AB; Sodroski J PLoS Pathog; 2009 Apr; 5(4):e1000360. PubMed ID: 19343205 [TBL] [Abstract][Full Text] [Related]
16. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. Broder CC; Berger EA J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649 [TBL] [Abstract][Full Text] [Related]
17. CD4 activation of HIV fusion. Sattentau QJ Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202 [TBL] [Abstract][Full Text] [Related]
18. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells. Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Berger EA; Lifson JD; Eiden LE Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]